Track record · closed signal

PACS Group, Inc. (PACS) — closed signal from November 4, 2025

Target reached Published before the outcome was known, scored automatically when the window closed on February 2, 2026.

Predicted vs. what happened

PACS price · publication thesis → realized outcomesplit-adjusted
$12.00 Published $14.16 Target $33.76 Window close $43.08 Peak
$11.75 – $12.25Entry zone — fair-value band
$12.00Published — price the day we called it
$14.16Target — the price the thesis aimed for
$43.08Peak — highest point inside the window, not a realized return
$33.76Window close — end-of-window price, context only

What happened

Target reached

Reached its target in 13 days.

Peak price
$43.08
peak on January 13, 2026 — not a realized return
Peak gain
+259%
peak, from the publication price
Window close
$33.76
end-of-window price, context only
Days to target
13
Window
November 4, 2025 – February 2, 2026

The thesis — published November 4, 2025

Predicted growth
+18%
over the measurement window
Target price
$14.16
the price the thesis aimed for
Entry zone
$11.75 – $12.25
the fair-value band we waited for
Price at publication
$12.00
published November 4, 2025
Confidence
66%
how strongly the data lined up
Timeframe
Short-term (0–3 months)

PACS runs nursing centers well, and the stock looks washed out after heavy selling, which can set up a short-term rebound. Many investors like the company's quality and steady operations. However, some pricing models say the shares may already be expensive versus profits, so enthusiasm is toned down. Recent news shows strong resident levels and high care ratings. A bounce in the next 0-3 months is possible if pay rates and staffing costs cooperate.

Primary drivers

  • Facilities are mostly full and government quality scores are high
  • Investor mood is very positive thanks to solid day-to-day execution
  • Recent selling looks overdone, giving a potential short-term entry
  • Debate on price vs earnings keeps expectations more cautious

How it played out

PACS: target reached in 13 days

Lyra published PACS at $12 on 2025-11-04 with 18% expected growth and a $14.16 target. The thesis pointed to mostly full facilities, high government quality scores, positive investor mood around day-to-day execution, recent selling that looked overdone, and a debate on price versus earnings that kept expectations cautious.

Inside the window, PACS reached the target in 13 days. The stock later peaked at $43.08 on 2026-01-13, well above the target, with a 259% peak gain. It ended the window at $33.76. The thesis played out clearly.

What happened during the window

On 2025-11-20, Barron's reported that PACS Group posted earnings for the first time in a year. It reported third-quarter adjusted earnings of 32 cents per share and revenue of $1.34 billion, and gave a 2025 revenue outlook of $5.25 billion to $5.35 billion.

Prices are shown split- and dividend-adjusted, matching what public charts show today.

Share this receipt

A scored call, published before the outcome was known. Paste the link anywhere — it unfurls as the card above.

Lyra

Read the next call before it closes.

This is one signal, scored after the fact. Today’s picks come with the same plain-language thesis — published before anyone knows the outcome.